Phase 2 Pancreatitis Trial, Recruiting NCT07012772 Sponsor: Zhejiang University Condition: Pancreatitis
Back to Pancreatitis

Phase 2 Pancreatitis Trial, Recruiting

NCT07012772
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • Your overall health has been assessed by a doctor and falls within a low-to-moderate risk range (ASA classification I to III — confirm with trial site if unsure what this means for you)
  • You have read and signed a consent form agreeing to take part
  • You are scheduled to have a procedure called ERCP (a camera procedure to examine the digestive system) with sedation (medication to help you relax or sleep)
  • Your procedure is expected to take no longer than 45 minutes

Who may not be able to join:

  • You have a blood clotting disorder, a tendency to bleed from the mouth or nose, injuries to the mouth/throat lining, or a condition that makes it difficult to manage your airway
  • You have serious heart problems that significantly limit your physical activity (confirm with trial site)
  • You have severe kidney disease that requires dialysis before the procedure
  • You have advanced liver disease rated as "Child-Pugh class C" (confirm with trial site)
  • You have been diagnosed with COPD or another lung condition that requires you to use oxygen regularly or from time to time
  • You have raised pressure inside your skull
  • You currently have an infection in your nose, mouth, or throat
  • You have a fever (body temperature above 37.5°C)
  • You are pregnant or currently breastfeeding
  • You have a known allergy to sedative medications (such as propofol) or to medical adhesive materials
  • Your procedure is needed urgently/as an emergency
  • You have injuries to multiple parts of your body
  • Your blood oxygen level is below 95% while breathing normal room air before the procedure
  • Your body mass index (BMI) is below 18.5 or above 30
  • You are currently taking part in another clinical trial
  • The trial investigators decide there is another reason you would not be suitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 86+18616514088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Zhejiang University
Registry
ClinicalTrials.gov
Start date
12 June 2025
Est. completion
30 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of hypoxia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov